| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6699897652ee9a3e7e01daff30a09494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35dedf3436d8c7d2ae052abf705db7b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c7be058794cda4a79f12af222660463
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e68831fd7a18aca55fb4556e3277ad6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9821cfb10b47f8b8740f305dc64fdbeb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48384 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-06 |
| filingDate |
2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a965d9685840a7ef61aa7e9c363ede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce7a4b27719d739b166f818cb50a9cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ace1616ee0c07e5ddc9925de1fafde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d5a993fa88f59ad2c8f3b2fbb3e3740 |
| publicationDate |
2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9364555-B2 |
| titleOfInvention |
Pederin and psymberin agents |
| abstract |
Compounds that include a pederin, psymberin or pederin/psymberin chimera scaffold. The pederin scaffold includes a substituent at the C10 and/or C13 position that may include a linker that may be conjugated to a targeting moiety. The psymberin scaffold includes a substituent at the C8 and/or C11 positions that may include a linker that may be conjugated to a targeting moiety. The pederin/psymberin chimera scaffold includes a substituent at the C10 and/or C13 position that may include a linker that may be conjugated to a targeting moiety. The pederin, psymberin or pederin/psymberin chimera scaffold may be modified to include substituents at positions other than the C10 or C13 of pederin, or the C8 and C11 of psymberin. |
| priorityDate |
2011-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |